SEC Form 4 research
| Issuer | NewAmsterdam Pharma Co N.V. |
|---|---|
| Tickers | NAMS |
| Reporting owners | 34 |
| Officers and directors | 9 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-09-30 | Kastelein Johannes Jacob Pieter | S | 50,246 | $25.03 | Not reported |
| 2026-09-15 | 2026-09-14 | Davidson Michael H. | P | 10,000 | $22.65 | Not reported |
| 2026-09-09 | 2026-09-04 | Smither John W | S | 1,600 | $25.32 | Not reported |
| 2026-09-03 | 2026-09-01 | Gunning Robert William | A | 3,200 | $0 | Not reported |
| 2026-09-03 | 2026-09-01 | Gunning Robert William | A | 14,000 | $0 | Not reported |
| 2026-08-25 | 2026-08-24 | Kastelein Johannes Jacob Pieter | S | 125,000 | $26.91 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.